In their Article in The Lancet Global Health, Holly Burke and colleagues¹ make an important contribution to the literature on the self-administration of the injectable contraceptive subcutaneous depot medroxyprogesterone acetate (DMPA-SC). In this large randomised controlled trial done in Malawi, the investigators used robust methods and frequent participant follow-up and found a significantly higher rate of 1 year DMPA-SC continuation among women who self-administered injections compared with those assigned to return to a provider for the injections, as is usual.

中文翻译：

---

DMPA自我管理可以改善避孕药具的获取，延续和自治

Holly Burke及其同事¹在《柳叶刀全球健康》杂志上的文章中，为可注射避孕皮下注射剂醋酸甲羟孕酮（DMPA-SC）的自我给药方面的文献做出了重要贡献。在马拉维进行的这项大型随机对照试验中，研究人员使用了强有力的方法，并频繁地进行了参与者随访，发现与给予返回提供者的女性相比，自我管理注射的女性中1年DMPA-SC延续的发生率明显更高。像往常一样注射。